HealthcareServices

Plasmid DNA Manufacturing Market Size Forecast: Revenue and CAGR by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Plasmid DNA Manufacturing Industry Expected To Reach By 2029, Starting From 2025 Levels?

The plasmid dna manufacturing market size has seen significant expansion in recent years. It is projected to increase from $2.34 billion in 2024 to $2.89 billion in 2025, achieving a compound annual growth rate (CAGR) of 23.6%. This historical growth can be attributed to various factors such as the application of plasmid DNA in industrial processes, its role in creating genetically modified organisms, its use in producing monoclonal antibodies within cell lines, international health initiatives, its deployment in bioremediation and other environmental applications, and ongoing microbiome studies.

The plasmid dna manufacturing market is projected to undergo significant expansion in the coming years. It is anticipated to grow to $6.46 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 22.2%. This growth during the forecast period is attributed to the increasing utilization of plasmid DNA in developing DNA vaccines for infectious diseases, its growing adoption in the creation of antibody-drug conjugates, personalized therapies, its application in developing cancer treatments, and various intellectual property advancements. Prominent trends for the forecast period include intensified activity in licensing agreements for plasmid DNA technologies, the emergence of customized solutions, implementation of cost reduction strategies, widespread use of high-throughput screening, and the development of scalable manufacturing solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp

Which Drivers Are Supporting Growth Of The Plasmid DNA Manufacturing Market?

The increasing adoption of gene therapy is anticipated to drive the expansion of the plasmid DNA manufacturing market in the future. Gene therapy, a medical intervention, involves altering or manipulating an individual’s genes to address or avert illness. Its rise can be attributed to progress in genetic engineering technologies, heightened investment in research and development, successful outcomes in clinical trials, and the rising occurrence of genetic disorders, collectively underscoring its capacity to offer lasting or permanent treatments. Plasmid DNA manufacturing plays a crucial role in gene therapy by producing the necessary vectors to deliver therapeutic genes into cells, thereby enabling the treatment of genetic disorders. For example, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that the count of gene therapies in Phase III clinical trials increased by 10% in Q3 2023, marking the initial quarterly rise since Q3 2022. Consequently, the expanding acceptance of gene therapy is fueling the growth of the plasmid DNA manufacturing market.

What Are The Primary Types Of Segments Analyzed In The Plasmid DNA Manufacturing Market?

The plasmid dna manufacturingmarket covered in this report is segmented –

1) By Grade: Research And Development Grade; Good Manufacturing Practice (GMP) Grade

2) By Development Phase: Pre-Clinical Therapeutics; Clinical Therapeutics; Marketed Therapeutics

3) By Disease: Infectious Disease; Cancer; Genetic Disorder; Other Diseases

4) By Application: Deoxyribonucleic Acid (DNA) Vaccines; Cell And Gene Therapy; Immunotherapy; Other Applications

Subsegments:

1) By Research And Development Grade: Small-scale Plasmid DNA Production; Preclinical Research Plasmid DNA

2) By Good Manufacturing Practice (GMP) Grade: Clinical Trial Material Production; Commercial-Scale Plasmid DNA Production

Which Market Trends Are Creating New Opportunities In The Plasmid DNA Manufacturing Industry?

Leading companies within the plasmid DNA manufacturing market are pioneering advanced bioprocessing technologies to bolster the efficiency, scalability, and quality of plasmid DNA production. These innovations are intended to optimize the manufacturing workflow, decrease production expenditures, and confirm that the plasmid DNA adheres to rigorous regulatory benchmarks for therapeutic uses. For example, in January 2023, Charles River Laboratories, a US-based pharmaceutical company, introduced its eXpDNA platform, specifically engineered for the efficient generation and purification of superior-quality plasmid DNA. This platform integrates sophisticated bioprocessing techniques, adaptable production methodologies, and stringent quality assurance protocols to yield plasmid DNA that satisfies the exacting criteria for therapeutic and clinical applications. The eXpDNA platform finds widespread utility in gene therapy, DNA vaccine development, and various other biopharmaceutical contexts that require high yield, purity, and consistency.

Which Leading Players Are Enhancing Their Plasmid DNA Manufacturing Market Presence Worldwide?

Major companies operating in the plasmid DNA manufacturing market are Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc., Charles River Laboratories, Recipharm AB, Kaneka Corp., Genscript Biotech Corporation, Aldevron LLC, Genewiz, OriGene Technologies, Celonic AG, Creative Biogene, Cellectis, Synbio Technologies, VectorBuilder Inc., Altogen Biosystems, Addgene, Andelyn Biosciences, AGC Biologics, VGXI, BioCat GmbH, GeneCopoeia, PlasmidFactory GmbH & Co. KG, Akron Biotech, PackGene Biotech lnc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

How Is Plasmid DNA Manufacturing Market Demand Varying Across Different Regions?

North America was the largest region in the plasmid DNA manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmid DNA manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Plasmid DNA Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15895&type=smp

Browse Through More Reports Similar to the Global Plasmid DNA Manufacturing Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Dna Repair Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-repair-drugs-global-market-report

Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795